Today, I have sent emails to NICE and the NRLS team.

NICE - to see if data from the NRLS is looked at within the scope of a guideline review and to see if they would support the NRLS being used to report harms from non-pharmaceutical 'treatments'.

NRLS - To ask if non-pharmaceutical 'treatment' harms could be included within the scope of the NRLS. The system is being overhauled and rebranded so, in my mind, now is the perfect time to widen the scope.

See the previous update if you don't have a clue what I am talking about when I say 'NRLS'.

Onwards and upwards!